查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1808858

滴蟲快速檢測市場，按檢測類型、樣本類型、最終用戶、國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Trichomonas Rapid Testing Market, By Test Type, By Sample Type, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年，滴蟲快速檢測市場規模價值 4.69 億美元，2025 年至 2032 年的複合年成長率為 5.2%。

滴蟲快速檢測市場圍繞著快速檢測陰道滴蟲感染（一種常見的性傳染病）的診斷工具的開發、製造和終端用戶。與傳統的實驗室方法相比，這些快速檢測能夠更快地獲得結果，從而能夠及時診斷和治療。人們對性傳染感染的認知不斷提高，對生殖健康的重視程度不斷提高，這推動了相關需求。分子診斷和即時檢測設備的技術進步進一步拓展了市場機會。在臨床環境中提供易於使用且經濟高效的快速檢測，可增強患者管​​理，尤其是在資源有限的環境中。

此外，全球性活躍人口的增加和醫療基礎設施的改善也是推動因素。監管機構對加快診斷核准的支持正在加速市場成長。此外，旨在減少性傳染感染傳播的篩檢活動和措施的增加也使市場受益。整體而言，市場正朝著更靈敏、更便利、更便攜的檢測解決方案發展。挑戰包括需要更高的特異性和靈敏度以避免錯誤結果，以及其他診斷方法的競爭。

滴蟲快速檢測市場-市場動態

性傳染感染盛行率的上升推動了對快速診斷的需求。

全球性傳染病發生率的不斷上升，迫切需要快速可靠的診斷工具。傳統的檢測方法通常需要較長的處理時間和專門的實驗室基礎設施，這可能會延遲診斷和治療。快速檢測毛滴蟲感染可以幫助醫護人員更有效地識別和管理病例，從而降低傳播率。

早期發現對於控制疫情爆發和改善患者預後尤為重要。此外，性健康意識的提高以及政府支持的篩檢計畫也促進了這些快速檢測的廣泛應用。在資源匱乏、實驗室設施匱乏的地區，這種需求更凸顯，使得即時快速檢測成為不可或缺的醫療保健工具。這項驅動力與遏制性傳染感染傳播和改善全球生殖健康的公共衛生目標緊密契合。

滴蟲快速檢測市場-關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 5.2%。

根據檢測類型細分，預計分子快速檢測將在 2024 年佔據最大市場佔有率

根據樣本類型細分，陰道/尿道拭子是 2024 年的主要樣本類型

根據最終用戶細分，醫院是 2024 年的主要樣本類型

按地區分類，北美是 2024 年的主要收入來源

滴蟲快速檢測市場-細分分析：

全球毛滴蟲快速檢測市場根據檢測類型、樣本類型、最終用戶和地區進行細分。

根據檢測類型，市場分為三類：分子快速檢測、免疫層析檢測和酵素連結免疫吸附試驗。在檢測類型中，分子快速檢測因其在檢測陰道毛滴蟲方面卓越的準確性和靈敏度而佔據市場主導地位。核酸擴增檢測 (NAAT) 等分子方法即使在病原體含量較低的情況下也能提供可靠的檢測，而免疫測定或層析檢測可能會漏檢這些情況。

這些檢測週轉時間短，可在照護端或照護端附近使用，因此在臨床環境中頗具吸引力。儘管成本通常較高，但其臨床效益和改善的患者預後證明，它們在醫療保健提供者中相當受歡迎。持續的進步使分子快速檢測更加便捷易用，從而提高了採用率。此外，這些檢測通常整合到可同時檢測多種性傳染感染的多重平台中，這進一步增強了它們的市場吸引力。

根據樣本類型，市場分為兩類：陰道/尿道拭子和尿液樣本。在毛滴蟲快速檢測市場中，陰道拭子和尿道拭子是最主要的樣本類型。這些拭子因其較高的診斷準確性，尤其是在與快速抗原和核酸擴增檢測 (NAAT) 配合使用時，在臨床環境中更受青睞。

它們廣泛應用於醫院、診斷實驗室和性健康診所，幾分鐘內即可提供可靠的結果。拭子檢測的一致性和監管認可使其成為黃金標準，尤其適用於有症狀的女性患者。雖然尿液樣本因其非侵入性且適合在家檢測而日益受到關注，但拭子憑藉其卓越的靈敏度和廣泛的應用，仍保持領先地位。

滴蟲快速檢測市場-地理洞察

北美市場，尤其是美國和加拿大，是全球毛滴蟲快速檢測市場的重要貢獻者。先進的醫療基礎設施、快速診斷工具的廣泛普及以及積極主動的政府篩檢項目，共同推動了該地區的成長。擁有強大研發能力和終端用戶網路的關鍵市場參與者的存在，為產品創新和可及性提供了支持。

針對性傳播感染預防和早期診斷的公共衛生措施已完善，快速檢測試劑盒的需求穩定。該地區也受益於患者認知度高以及支持診斷檢測的保險覆蓋政策。北美的監管框架鼓勵快速核准新型檢測技術，進一步推動了市場擴張。

美國憑藉其完善的醫療保健體系和日益重視的性健康篩檢，在北美滴蟲快速檢測市場佔據主導地位。該國為性傳染感染（STI）防治計畫提供了充足的資金，從而促進了對高效診斷解決方案的需求。大型醫療機構和診所擴大採用快速檢測技術，以提高患者吞吐量和臨床療效。包括基於核酸擴增的快速檢測在內的技術創新日益普及，提高了靈敏度並簡化了操作。

對降低醫療成本和減少就診次數的日益關注也推動了即時檢測的普及。市場參與者受益於FDA簡化的監管途徑，從而加快了新產品的上市速度。然而，替代檢測方法的競爭以及持續產品驗證的需求等挑戰仍然存在。診斷公司與醫療保健機構之間的合作進一步增強了美國市場的成長潛力。

滴蟲快速檢測市場-競爭格局：

滴蟲快速檢測市場競爭激烈，主要參與者專注於產品創新、合作夥伴關係和策略性收購，以鞏固其市場地位。各公司正在加大研發投入，以提高檢測靈敏度、縮短週轉時間並增強易用性。同時檢測多種性傳染感染的多重檢測平台的趨勢日益明顯。市場參與者積極與醫療保健機構和政府機構合作，推廣篩檢計劃，從而擴大其地理覆蓋範圍。

定價策略和報銷政策對市場競爭有重大影響，促使參與者在成本效益和技術進步之間取得平衡。合規性和及時的產品核准是至關重要的競爭因素。規模較小的參與者通常專注於利基市場或區域市場，而規模較大的公司則利用廣泛的終端用戶網路和品牌知名度。總體而言，市場以持續創新和不斷變化的客戶需求為特徵，推動競爭態勢。

最新動態：

2025 年 5 月，Quidel 公司宣布推出改良的滴蟲分子快速檢測方法，該檢測方法靈敏度更高，結果更快。

目錄

第1章：滴蟲快速檢測市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 滴蟲快速檢測市場片段（依檢測類型）
    • 滴蟲快速檢測市場片段（依樣本類型）
    • 毛滴蟲快速檢測市場片段（按最終用戶）
    • 滴蟲快速檢測市場（按國家/地區分類）
    • 毛滴蟲快速檢測市場（按地區）
  • 競爭洞察

第3章：滴蟲快速檢測關鍵市場趨勢

  • 滴蟲快速檢測市場促進因素
    • 市場促進因素的影響分析
  • 滴蟲快速檢測市場限制
    • 市場限制的影響分析
  • 滴蟲快速檢測市場機遇
  • 滴蟲快速檢測市場未來趨勢

第4章：滴蟲快速檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：滴蟲快速偵測市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：滴蟲快速偵測市場格局

  • 2024 年毛滴蟲快速檢測市場佔有率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：滴蟲快速偵測市場－依檢測類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 分子快速檢測
    • 免疫層析測試
    • 酵素連結免疫吸附測定

第8章：滴蟲快速檢測市場－依樣本類型

  • 概述
    • 依樣本類型進行細分佔有率分析
    • 陰道/尿道拭子
    • 尿液樣本

第9章：毛滴蟲快速偵測市場－按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 診斷實驗室
    • 診所和醫生辦公室
    • 即時檢驗中心

第 10 章：毛滴蟲快速偵測市場-依地域分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美滴蟲快速檢測主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按樣本類型）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲滴蟲快速檢測主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模及預測（依樣本類型）
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區滴蟲快速檢測主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依測試類型）
    • 亞太地區市場規模及預測（依樣本類型）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲滴蟲快速檢測主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按測試類型）
    • 拉丁美洲市場規模及預測（依樣本類型）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的滴蟲快速檢測主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依測試類型）
    • MEA 市場規模及預測（依樣品類型）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：主要供應商分析-毛滴蟲快速檢測產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Quidel Corporation
    • Hologic, Inc.
    • Sekisui Diagnostics
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories
    • Meridian Bioscience, Inc.
    • Siemens Healthineers
    • Roche Diagnostics
    • Alere Inc. (now part of Abbott)
    • Cepheid
    • F. Hoffmann-La Roche Ltd
    • Luminex Corporation
    • BioMerieux SA
    • Ortho Clinical Diagnostics
    • Mobidiag Oy
    • GenProbe, Inc.
    • Diasorin SpA
    • Nanosphere, Inc.

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5505

Trichomonas Rapid Testing Market size was valued at US$ 469 Million in 2024, expanding at a CAGR of 5.2% from 2025 to 2032.

The Trichomonas Rapid Testing Market revolves around the development, manufacturing, and End-user of diagnostic tools designed to quickly detect Trichomonas vaginalis infections, a common sexually transmitted infection. These rapid tests offer faster results compared to traditional laboratory-based methods, enabling timely diagnosis and treatment. Growing awareness of sexually transmitted infections and increased emphasis on reproductive health have fueled demand. Technological advancements in molecular diagnostics and point-of-care testing devices have further expanded market opportunities. The availability of easy-to-use, cost-effective rapid tests in clinical settings enhances patient management, especially in resource-limited environments.

Moreover, the rise in sexually active populations and improved healthcare infrastructure globally are contributing factors. Regulatory support for faster diagnostic approvals is accelerating market growth. The market also benefits from increased screening campaigns and initiatives aimed at reducing STI transmission. Overall, the market is progressing towards more sensitive, user-friendly, and portable testing solutions. Challenges include the need for high specificity and sensitivity to avoid false results and competition from alternative diagnostic methods.

Trichomonas Rapid Testing Market- Market Dynamics

Rising prevalence of sexually transmitted infections drives demand for rapid diagnostics.

The increasing incidence of sexually transmitted infections worldwide has created an urgent need for quick and reliable diagnostic tools. Traditional testing methods often require extended processing times and specialized laboratory infrastructure, which can delay diagnosis and treatment. Rapid testing for Trichomonas infections allows healthcare providers to identify and manage cases more efficiently, reducing transmission rates.

Early detection is particularly critical in controlling outbreaks and improving patient outcomes. Additionally, the rise in awareness about sexual health and government-supported screening programs promotes wider adoption of these rapid tests. This demand is amplified in low-resource settings where laboratory facilities are scarce, making point-of-care rapid tests an essential healthcare tool. The driver aligns closely with public health goals to curb STI spread and improve reproductive health globally.

Trichomonas Rapid Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.2% over the forecast period (2025-2032)

Based on Test Type segmentation, Molecular Rapid Tests were predicted to show maximum market share in the year 2024

Based on Sample Type segmentation, Vaginal/Urethral Swabs was the leading Sample Type in 2024

Based on End-user segmentation, Hospitals was the leading Sample Type in 2024

On the basis of region, North America was the leading revenue generator in 2024

Trichomonas Rapid Testing Market- Segmentation Analysis:

The Global Trichomonas Rapid Testing Market is segmented on the basis of Test Type, Sample Type, End-user, and Region.

The market is divided into three categories based on Test Type: Molecular Rapid Tests, Immunochromatographic Tests, and Enzyme Immunoassays. Among Test Types, Molecular Rapid Tests dominate the market due to their superior accuracy and sensitivity in detecting Trichomonas vaginalis. Molecular methods, such as nucleic acid amplification tests (NAATs), provide reliable detection even in cases of low pathogen load, which immunoassays or chromatographic tests may miss.

These tests offer rapid turnaround times and can be used at or near the point of care, making them attractive for clinical settings. Despite generally higher costs, the clinical benefits and improved patient outcomes justify their preference among healthcare providers. Continuous advancements have made molecular rapid tests more user-friendly and accessible, thus increasing adoption rates. Additionally, these tests are often integrated into multiplex platforms that detect multiple STIs simultaneously, further enhancing their market appeal.

The market is divided into two categories based on Sample Type: Vaginal/Urethral Swabs, Urine Samples. In the Trichomonas rapid testing market, vaginal and urethral swabs are the most dominant sample type. These swabs are preferred in clinical settings due to their high diagnostic accuracy, particularly when used with rapid antigen and nucleic acid amplification tests (NAATs).

They are widely adopted in hospitals, diagnostic labs, and sexual health clinics, offering reliable results within minutes. The consistency and regulatory acceptance of swab-based testing make it the gold standard, especially for symptomatic female patients. While urine samples are gaining traction for being non-invasive and suitable for at-home testing, swabs continue to lead due to their superior sensitivity and widespread usage.

Trichomonas Rapid Testing Market- Geographical Insights

The North American market, particularly the United States and Canada, is a significant contributor to the global Trichomonas rapid testing market. Advanced healthcare infrastructure, widespread availability of rapid diagnostic tools, and proactive government screening programs boost regional growth. The presence of key market players with strong R&D capabilities and End-user networks supports product innovation and accessibility.

Public health initiatives targeting STI prevention and early diagnosis are well-established, creating steady demand for rapid testing kits. The region also benefits from a high level of patient awareness and insurance coverage policies that support diagnostic testing. Regulatory frameworks in North America encourage rapid approvals of novel testing technologies, further driving market expansion.

The U.S. dominates the North American Trichomonas rapid testing market due to its sophisticated healthcare system and increasing emphasis on sexual health screening. The country has robust funding for STI prevention and control programs, fostering demand for efficient diagnostic solutions. Major healthcare providers and clinics increasingly adopt rapid testing to improve patient throughput and clinical outcomes. Technological innovation, including nucleic acid amplification-based rapid tests, is prevalent, offering enhanced sensitivity and ease of use.

The growing focus on reducing healthcare costs and hospital visits also encourages point-of-care testing adoption. Market players benefit from streamlined regulatory pathways by the FDA, facilitating quicker market entry for new products. However, challenges such as competition from alternative testing methods and the need for continuous product validation remain. Collaborations between diagnostic companies and healthcare organizations further strengthen the market's growth potential in the U.S.

Trichomonas Rapid Testing Market- Competitive Landscape:

The Trichomonas rapid testing market is highly competitive, with key players focusing on product innovation, partnerships, and strategic acquisitions to strengthen their market positions. Companies are investing in research and development to improve test sensitivity, reduce turnaround times, and enhance ease of use. The trend towards multiplex testing platforms that detect multiple sexually transmitted infections simultaneously is gaining traction. Market participants actively expand their geographic footprints by collaborating with healthcare providers and government bodies to promote screening initiatives.

Pricing strategies and reimbursement policies significantly impact market competition, encouraging players to balance cost-effectiveness with technological advancement. Regulatory compliance and timely product approvals are crucial competitive factors. Smaller players often focus on niche segments or regional markets, while larger companies leverage extensive End-user networks and brand recognition. Overall, the market is marked by continuous innovation and evolving customer needs, driving competitive dynamics.

Recent Developments:

In May 2025, Quidel Corporation announced the launch of an improved molecular rapid test for Trichomonas with enhanced sensitivity and faster results.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRICHOMONAS RAPID TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Quidel Corporation
  • Hologic, Inc.
  • Sekisui Diagnostics
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Meridian Bioscience, Inc.
  • Siemens Healthineers
  • Roche Diagnostics
  • Alere Inc. (now part of Abbott)
  • Cepheid
  • F. Hoffmann-La Roche Ltd
  • Luminex Corporation
  • BioMerieux SA
  • Ortho Clinical Diagnostics
  • Mobidiag Oy
  • GenProbe, Inc.
  • Diasorin S.p.A
  • Nanosphere, Inc.

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Molecular Rapid Tests
  • Immunochromatographic Tests
  • Enzyme Immunoassays

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vaginal/Urethral Swabs
  • Urine Samples

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Clinics and Physician Offices
  • Point-of-Care Testing Centers

GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Trichomonas Rapid Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Trichomonas Rapid Testing Market Snippet by Test Type
    • 2.1.2. Trichomonas Rapid Testing Market Snippet by Sample Type
    • 2.1.3. Trichomonas Rapid Testing Market Snippet by End-user
    • 2.1.4. Trichomonas Rapid Testing Market Snippet by Country
    • 2.1.5. Trichomonas Rapid Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Trichomonas Rapid Testing Key Market Trends

  • 3.1. Trichomonas Rapid Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Trichomonas Rapid Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Trichomonas Rapid Testing Market Opportunities
  • 3.4. Trichomonas Rapid Testing Market Future Trends

4. Trichomonas Rapid Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Trichomonas Rapid Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Trichomonas Rapid Testing Market Landscape

  • 6.1. Trichomonas Rapid Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Trichomonas Rapid Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Molecular Rapid Tests
    • 7.1.3. Immunochromatographic Tests
    • 7.1.4. Enzyme Immunoassays

8. Trichomonas Rapid Testing Market - By Sample Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
    • 8.1.2. Vaginal/Urethral Swabs
    • 8.1.3. Urine Samples

9. Trichomonas Rapid Testing Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Clinics and Physician Offices
    • 9.1.5. Point-of-Care Testing Centers

10. Trichomonas Rapid Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Trichomonas Rapid Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Trichomonas Rapid Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Trichomonas Rapid Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Trichomonas Rapid Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Trichomonas Rapid Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Trichomonas Rapid Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Quidel Corporation
    • 11.2.2. Hologic, Inc.
    • 11.2.3. Sekisui Diagnostics
    • 11.2.4. Abbott Laboratories
    • 11.2.5. Becton Dickinson and Company
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. Bio-Rad Laboratories
    • 11.2.8. Meridian Bioscience, Inc.
    • 11.2.9. Siemens Healthineers
    • 11.2.10. Roche Diagnostics
    • 11.2.11. Alere Inc. (now part of Abbott)
    • 11.2.12. Cepheid
    • 11.2.13. F. Hoffmann-La Roche Ltd
    • 11.2.14. Luminex Corporation
    • 11.2.15. BioMerieux SA
    • 11.2.16. Ortho Clinical Diagnostics
    • 11.2.17. Mobidiag Oy
    • 11.2.18. GenProbe, Inc.
    • 11.2.19. Diasorin S.p.A
    • 11.2.20. Nanosphere, Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us